Use of G-CSF to reduce acute rejection

Details Use of G-CSF to reduce acute rejection Use of G-CSF to reduce acute rejection

1994-04-15

1996-07-16

Sayala, Chhaya D.

Drug, bio-affecting and body treating compositions

Involving sex selection or contraception

514 12, A61K 4505

Patent

active

055364950

ABSTRACT:
Reduction of occurrence of acute rejection of organ transplants is achieved by treatment with a G-CSF protein product.

REFERENCES:
patent: 4810643 (1989-03-01), Souza
patent: 4904584 (1990-01-01), Shaw
patent: 5166322 (1992-11-01), Shaw et al.
patent: 5194592 (1993-03-01), Yoshida
patent: 5214132 (1993-05-01), Kuga et al.
patent: 5218092 (1993-06-01), Sasaki et al.
patent: 5241072 (1993-08-01), Colon et al.
Parenteau, G. L. et al., Transplantation, vol. 54(6), pp. 963-68, 1992.
Ishizone et al., J Pediatric Surgery, vol. 29(4), pp. 510-513, Apr. 1994.
Billingham, "Dilemma of Variety of Histopathologic Grading Systems for Acute Cardiac Allograft Rejection by Endomyocardial Biopsy", J. Heart Transplant., 9:272-276 (1990).
Colquhoun et al., "Reversal of Neutropenia with Granulocyte Colony-Stimulating Factor without Precipitating Liver Allograft Rejection", Transplantation, 56:755-758 (1993).
Diflo et al., "Simultaneous use of Ganciclovir and Granulocyte Colony Stimulating Factor in Liver Transplant Recipients", Hepatology, 16:278A (1992).
Foster et al., "Blood and Graft Eosinophilia as Predictors of Rejection in Human Liver Transplantation", Transplantation, 47:72-74 (1989).
Gabrilove, "Introduction and Overview of Hematopoietic Growth Factors", Seminars in Hematology,26:1-4 (1989).
Gorgen et al., "Granulocyte Colony-Stimulating Factor Treatment Protects Rodents Against Lipopolysaccharide-Induced Toxicity Via Suppression of Systemic Tumor Necrosis Factor-.alpha.", J. Immunol., 149:918-924 (1992).
Jones et al., "Growth factors in haemopoiesis", Balliere's Clinical Hematology, 2:83-111 (1989).
Kuga et al., "Mutagenesis of Human Granulocyte Colony Stimulating Factor", Biochem. Biophys. Res. Comm., 159:103-111 (1989).
Lachaux et al., "Treatment with lenograstim (glycosylated recombinant human granulocyte colony-stimulating factor) and orthotopic liver transplantation for glycogen storang disease type Ib", J. Pediatrics, 123:1005-1008 (1993).
Lu et al., "Disulfide and Secondary Structures of Recombinant Human Granulocyte Colony Stimulating Factor", Arch. Biochem. Biophys., 268:81-92 (1989).
Moore et al., "Synergy of interleukin 1 and granulocyte colony-stimulating factor: In vivo stimulation of stem-cell recovery and hematopoietic regeneration following 5-fluorouracil treatment of mice", Proc. Nat'l. Acad. Sci. (USA), 84:7134-7138 (1987).
Nagaata et al., "The chromosomal gene structure and two mRNAs for human granulocyte colony-stimulating factor", EMBO J.,5:575-581 (1986).
Ono et al., "Improved technique of heart transplantation in rats", J. Thoracic Cardiovasc. Surg., 57:225-229 (1969).
Paradis et al., "Distinguishing Between Infection, Rejection, and the Adult Respiratory Distress Syndrome After Human Lung Transplantation",J. Heart Lung Transplant., 11:S232-236 (1992).
Souza et al., "Recombinant Human Granulocyte Colony-Stimulating Factor: Effects on Normal and Leukemic Myeloid Cells", Science, 232:61-65 (1986).
Welte et al., "Purification and biochemical characterization of human pluripotent hematopoietic colony-stimulating factor", Proc. Nat'l. Acad. Sci. (USA), 82:1526-1530 (1985).
Williams et al., "Role of Liver Allograft Biopsy in Patient Management", Seminars in Liver Disease, 12:60-72 (1992).
Wright et al., "Granulocyte Colony-Stimulating Factor (GCSF) Combined with .alpha. Interferon (.alpha. IFN) for Treatment of Liver Allograft Recipients with Viral Hepatitis", Hepatology, 14:48A (1991).
Adams et al., "Neutrophil Activation--An Important Cause of Tissue Damage During Liver Allograft Rejection?," Transplantation, 50:86-91 (1990).
Dale, "Alterations in Laboratory Findings--Section 11", in Harrison's Principles of Internal Medicine, p. 284, McGraw-Hill, New York (1980).
Foker et al., "Principles of Immunosuppression," in Davis-Christopher Textbook of Surgery, pp. 496-515, W. B. Saunders, Philadelphia, PA (1981).
Nery et al., "Incidence and Outcome of Acute Rejection in Liver Transplantation," Transplantation Proc., XX(3, Supp. 3) :375-377 (1988).
Reich, Hematology,p. 253, Little, Brown and Company, Boston (1978).
Tamaki et al., "Adverse Effect of rhG-CSF in the Process of Rat Heart Allograft Rejection." Transplantation Proc.,26:2311-2312 (1994).

Affiliated with

Also associated with

Rating

Use of G-CSF to reduce acute rejection does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of G-CSF to reduce acute rejection, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of G-CSF to reduce acute rejection will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1782816